Axial spondyloarthritis of the lumbar spine with active inflammation confirmed by MRI or clinical criteria but without the structural sacroiliac joint damage visible on plain radiographs that defines ankylosing spondylitis.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Spine
Documentation tips
What should appear in the chart to support M45.A6.
Source · Editorial brief grounded in 6 cited references ↓
- Record the treating physician's explicit diagnosis of 'non-radiographic axial spondyloarthritis' — do not infer this code from a generic 'inflammatory back pain' note.
- Document MRI findings (sacroiliac joint bone marrow edema, periarticular inflammation) alongside the explicit statement that plain radiographs show no definitive sacroiliitis.
- Specify 'lumbar region' as the primary location in the assessment; if lumbosacral involvement is also described, evaluate whether M45.A7 or M45.AB better captures the documented anatomy.
- Record HLA-B27 status, CRP, and ESR results in the note — these support medical necessity for biologics tied to this diagnosis and may be required in prior authorization submissions.
- Note the duration and pattern of back pain (inflammatory pattern: worse with rest, better with activity, morning stiffness >30 minutes) to substantiate the inflammatory spondyloarthritis diagnosis versus mechanical low back pain.
Related CPT procedures
Procedure codes commonly billed with M45.A6. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M45.A6 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Coding M45.6 (ankylosing spondylitis, lumbar region) when plain X-rays are normal — radiographic sacroiliitis is required for AS; use M45.A6 when imaging is MRI-only positive.
- Defaulting to M46.8 (other specified inflammatory spondylopathies) or M54.51 (vertebrogenic low back pain) out of habit — M45.A6 has been the correct specific code since October 1, 2021.
- Using M45.A0 (unspecified sites) when the provider has documented lumbar involvement — always code to the highest level of specificity supported by documentation.
- Selecting M45.A7 (lumbosacral region) when the note says 'lumbar' — lumbosacral implies involvement at the L5-S1 junction and below; lumbar alone maps to M45.A6.
- Failing to verify payer system acceptance of M45.A6 before submitting — some payers were slow to update their edits for codes introduced in the FY2022 cycle; a rejection is a payer-system issue, not a code error.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M45.A6 applies when a rheumatologist or spine specialist has diagnosed non-radiographic axial spondyloarthritis (nr-axSpA) with symptoms localized to or predominantly affecting the lumbar region. The defining distinction from ankylosing spondylitis (M45.6, lumbar region) is the absence of radiographic sacroiliitis on plain X-ray. Patients typically present with chronic inflammatory low back pain, morning stiffness exceeding 30 minutes, and MRI-confirmed bone marrow edema at the sacroiliac joints — but plain films remain normal or show only equivocal changes. HLA-B27 positivity and elevated CRP/ESR commonly support the diagnosis but are not required for this code.
This subcategory (M45.A) was introduced effective October 1, 2021, specifically to give nr-axSpA its own coding space, separating it from ankylosing spondylitis and from the catch-all M46.8 (other specified inflammatory spondylopathies) that coders used before 2022. Use M45.A6 when documentation explicitly names nr-axSpA and identifies the lumbar region as the primary or documented site. If involvement spans the lumbosacral junction, M45.A7 is the correct code. For multi-region disease, M45.AB captures multiple sites.
Because nr-axSpA is the indication for several biologic therapies (IL-17A inhibitors, TNF inhibitors), payers scrutinize this code closely for medical necessity. Confirm that your payer's system recognizes M45.A6 — some legacy payer systems were slow to load the 2022 code additions. Document the imaging modality (MRI), the absence of radiographic sacroiliitis, and the treating specialist's explicit nr-axSpA diagnosis to support the code and the associated biologic prior authorization.
Sibling codes
Other billable codes under M45.A (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the key difference between M45.A6 and M45.6?
02Can I use M45.A6 if the provider documented 'axial spondyloarthritis' without specifying 'non-radiographic'?
03When should I use M45.AB instead of M45.A6?
04Is M45.A6 accepted by Medicare and commercial payers for biologic prior authorizations?
05Should I code separately for sacroiliitis when using M45.A6?
06Was there a valid code for nr-axSpA before M45.A6 existed?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M45-M49/M45-/M45.A6
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M45.A6
- 04ucb-usa.comhttps://www.ucb-usa.com/sites/default/files/2023-11/nr-axspa-icd-10.pdf
- 05aapc.comhttps://www.aapc.com/codes/coding-newsletters/my-orthopedic-coding-alert/icd-10-update-keep-an-eye-out-for-new-low-back-pain-spondyloarthritis-codes-169838-article
- 06findacode.comhttps://www.findacode.com/newsletters/aha-coding-clinic/icd/non-radiographic-axial-spondyloarthritis-I084020.html
Mira AI Scribe
The Mira AI Scribe captures the rheumatologist's or spine specialist's explicit nr-axSpA diagnosis, the documented lumbar region involvement, MRI findings confirming sacroiliac inflammation without plain-film sacroiliitis, HLA-B27 result, and inflammatory lab markers — preventing a downcode to unspecified (M45.A0) or the outdated M46.8 catch-all and strengthening the prior authorization record for biologic therapy.
See how Mira captures M45.A6 documentation